Clinical and experimental study for the treatment of tumor patients with depression by Xiao Chaihu Decoction

Shuguang Hospital affiliated with Shanghai University of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Age ranges from 18 to 75 years (including 18 and 75 years), and gender is not limited.
•2. The tumor was diagnosed by pathological cytology and/or histology.
•3. The general condition of patients was good, ECOG (0-2).
•4. SDS scale score >= 45 points and/or SAS scale score >= 40 points.
•5. Voluntarily accept the observation of this research plan, with clear thinking, clear expression and normal language and sensory response.
•6. Subjects were able to understand the study and sign informed consent and were willing to follow up.

•1. Patients with serious diseases such as heart, liver, kidney and hematopoietic system.
•2. Patients with symptomatic brain metastasis, and are expected to have brain metastasy-related complications and cognitive impairment.
•3. Pregnant or lactating women.
•4. Patients with uncontrollable mental disorders.
•5. Patients with active tuberculosis and other serious infectious diseases.
•6. Subjects received antianxiety, depression and antipsychotic drugs within 6 months.

发起方

Shuguang Hospital affiliated with Shanghai University of TCM